AMPLIPHI BIOSCIENCES CORP (APHB) Stock Price, Quote, News and Overview
NYSEARCA:APHB - NYSE Arca -
APHB Quote, Performance and Key Statistics
0.3179
-0.08 (-20.33%)
The current stock price of APHB is 0.3179 null. In the past month the price increased by 9.62%. In the past year, price decreased by -71.1%.
About APHB
Company Profile
AmpliPhi Biosciences Corporation, formerly known as Targeted Genetics Corporation, is a biotechnology company which develops anti-bacterial solutions for the treatment of gram negative bacterial infections that are often resistant to existing antibiotic treatments. AmpliPhi Biosciences Corporation is based in Seattle, Washington.
Company Info
AMPLIPHI BIOSCIENCES CORP
3579 VALLEY CENTRE DRIVE SUITE 100
SAN DIEGO CA 92130
CEO: Paul C. Grint
Phone: 804-827-2524
AMPLIPHI BIOSCIENCES CORP / APHB FAQ
What is the stock price of AMPLIPHI BIOSCIENCES CORP today?
The current stock price of APHB is 0.3179 null. The price decreased by -20.33% in the last trading session.
What is the ticker symbol for AMPLIPHI BIOSCIENCES CORP stock?
The exchange symbol of AMPLIPHI BIOSCIENCES CORP is APHB and it is listed on the NYSE Arca exchange.
On which exchange is APHB stock listed?
APHB stock is listed on the NYSE Arca exchange.
What is AMPLIPHI BIOSCIENCES CORP worth?
AMPLIPHI BIOSCIENCES CORP (APHB) has a market capitalization of 10.64M null. This makes APHB a Nano Cap stock.
What are the support and resistance levels for AMPLIPHI BIOSCIENCES CORP (APHB) stock?
AMPLIPHI BIOSCIENCES CORP (APHB) has a support level at 0.3 and a resistance level at 0.35. Check the full technical report for a detailed analysis of APHB support and resistance levels.
Should I buy AMPLIPHI BIOSCIENCES CORP (APHB) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of APHB, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of APHB, evaluating the profitability, health, valuation and growth aspects
- AMPLIPHI BIOSCIENCES CORP (APHB) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- AMPLIPHI BIOSCIENCES CORP (APHB) Sales and EPS estimates to see what analysts future expectations are.
- AMPLIPHI BIOSCIENCES CORP (APHB) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- AMPLIPHI BIOSCIENCES CORP (APHB) Insider and Institutional Ownership to learn about the owners and their transactions.
- AMPLIPHI BIOSCIENCES CORP (APHB) Stock Chart to make your own analysis
- AMPLIPHI BIOSCIENCES CORP (APHB) Latest news and press-releases to stay up to date.
Does AMPLIPHI BIOSCIENCES CORP (APHB) stock pay dividends?
APHB does not pay a dividend.
What is the Price/Earnings (PE) ratio of AMPLIPHI BIOSCIENCES CORP (APHB)?
AMPLIPHI BIOSCIENCES CORP (APHB) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.64).
APHB Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to APHB. When comparing the yearly performance of all stocks, APHB is a bad performer in the overall market: 85.39% of all stocks are doing better.
APHB Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to APHB. Both the profitability and financial health of APHB have multiple concerns.
APHB Financial Highlights
Over the last trailing twelve months APHB reported a non-GAAP Earnings per Share(EPS) of -0.64. The EPS increased by 60.25% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -130.95% | ||
| ROE | -253.84% | ||
| Debt/Equity | 0 |
APHB Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 100% to APHB. The Buy consensus is the average rating of analysts ratings from 1 analysts.